Publications by authors named "N Givalos"
Purpose: Replication Protein A (RPA) consists of three subunits (RPA1, RPA2 and RPA3) essential for all major DNA metabolic pathways. Although RPA seems to be a promising therapeutic target, its role in human cancers has not been fully elucidated. This is the first study investigating the expression of all the three RPA subunits in a series of 74 resected gastric carcinomas and analyzing the possible correlations with clinicopathologic parameters (histological type, grade, lymphovascular invasion, lymph node status and disease stage), Ki-67 proliferative index, Topoisomerase IIa expression and patients' survival.
View Article and Find Full Text PDFArticle Synopsis
- Appendiceal mucinous neoplasms show diverse clinical behaviors, with risks ranging from slow-growing forms that can recur to highly aggressive types leading to early death, primarily influenced by their grading and staging.
- A case study details a 52-year-old woman who had an incidental low-grade appendiceal mucinous neoplasm found during breast cancer follow-up; despite initial treatment with appendectomy, the tumor recurred in the cecum necessitating further surgery.
- The discussion underscores that patients with low-grade neoplasms confined to the appendix generally face minimal recurrence risk, although some experts recommend ongoing monitoring, especially when surgical margins are positive.
Minichromosome maintenance proteins (MCM) have recently emerged as novel proliferation markers with prognostic implications in several tumour types. This is the first study investigating MCM-2 and MCM-5 immunohistochemical expression in a series of ovarian adenocarcinomas and low malignant potential (LMP) tumours aiming to determine possible associations with clinicopathological parameters, the conventional proliferation index Ki-67, cell cycle regulators (p53, p27(Kip1), p21(WAF1) and pRb) and patients' outcome. Immunohistochemistry was applied in a series of 43 cases of ovarian LMP tumours and 85 cases of adenocarcinomas.
View Article and Find Full Text PDFReplication protein A (RPA), a component of the origin recognition complex, is required for stabilization of single-stranded DNA at early and later stages of DNA replication being thus critical for eukaryotic DNA replication. Experimental studies in colon cancer cell lines have shown that RPA protein may be the target of cytotoxins designed to inhibit cellular proliferation. This is the first study to investigate the expression of RPA1 and RPA2 subunits of RPA protein and assess their prognostic value in colon cancer patients.
View Article and Find Full Text PDF